bioMérieux Joins the Rory Staunton Foundation at the Second National Forum on Sepsis: “Let’s Save Lives”

bioMérieux, a world leader in the field of in vitro diagnostics, is proud to announce that for a second year they will be sponsoring the Rory Staunton Foundation’s (RSF) “National Forum on Sepsis,” the theme of which is “Let’s Save Lives.”  The event will be held on Sept. 16, 2015 in Washington D.C. and bioMérieux will provide a live webcasting of the event starting at 8:00 am via its educational website: www.SepsisKnowFromDay1.com.

“We have invited families from around the country that have been affected by sepsis to join us at the Second National Forum on Sepsis to lend their voices and their stories in memory of the 250,000 Americans who die from sepsis every year and to demand that government leaders take action and implement a long-overdue national sepsis protocol,” said Ciaran Staunton, co-founder of the RSF.

In partnership with the Sepsis Alliance and the RSF’s effort to tell the stories of sepsis patients, bioMérieux is featuring a unique “Faces of Sepsis” patient story each day on www.sepsisknowfromday1.com during the month of September.

“It is our great pleasure to help support the Rory Staunton Foundation’s annual Sepsis Forum,” said Stefan Willemsen, President and CEO, bioMérieux, Inc. “The RSF has made an incredible contribution to sepsis awareness in the U.S. and is working diligently to ensure that sepsis is detected rapidly and treated effectively. When detected early, the fatality rate of sepsis drops significantly.”

Misdiagnosed and untreated sepsis took the young life of Rory Staunton on April 1, 2012, at the age of 12. He received a cut from a fall in the gym at his school. A deadly toxin entered his body as a result. Early recognition may have saved him. A key initiative for the RSF this year is to educate teachers and school nurses to think of sepsis when a child is injured at school. The Foundation will also announce various other initiatives it is planning for 2016.  To learn more, visit http://rorystauntonfoundationforsepsis.org/

Thanks to the tireless efforts of Rory’s parents, Ciaran and Orlaith Staunton, New York State became the first state to require all hospitals to adopt best practices for the early identification and treatment of sepsis, a medical condition which is the number one killer in hospitals and the tenth leading cause of death in the United States. 

About bioMérieux

Pioneering Diagnostics

Pioneering Diagnostics

A world leader in the field of in vitro diagnostics for 50 years, bioMérieux is present in more than 150 countries through 42 subsidiaries and a large network of distributors. In 2014, revenues reached €1.698 billion with 88% of sales outside of France.

bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

bioMérieux is listed on the NYSE Euronext Paris market (Symbol: BIM – ISIN: FR0010096479).
Other information can be found at www.biomerieux-usa.com

Contacts

Media Relations

bioMérieux
Suzanne Jones
Tel: +1 919-479-3637
suzanne.jones@bioMérieux.com

Baker & Yorke
Tim Baker
Tel: + 1 216-338-8086
tbaker@baker-yorke.com